SARS-Cov-2 Process Control - Pellets
The product allows laboratories to validate the entire process of a molecular assay including extraction, reverse transcription, amplification, and detection. It is nuclease resistant and can be spiked into nuclease-rich patient samples such as nasal secretions or plasma.
Each kit contains 6 individually packaged lyophilized pellets.
Biosafety Level:
1
Product Format:
Helix Elite Synthetic Standard
Strain Characteristics:
The SARS-CoV-2 Process Control (Pellet) is made with RNA transcripts containing diagnostically relevant targets (CDC and WHO consensus sequences) encapsulated in a phage protein.
Includes human respiratory epithelial cells.
Nucleotides contained in each pellet (All positions in reference to GenBank Acc. NC_045512.2)
Orf1ab / RdRP: 12,690 ..12,797 | 13,342 ..13,460 | 14,080 ..14,186 | 15,431 ..15,530
S (Spike): 18,778 ..18,909 | 24,354 ..24,900
E (Envelope): 26,245 ..26,427 | 26,269 ..26,381
N (Nucleocapsid): 28,237 ..29,280
This kit is an essential tool for professionals seeking to conduct detailed analyses of neurotransmitter levels in urine, aiding in the understanding and management of various neurological and psychiatric conditions.
Internal Reference:
GEN - R9000
Website URL:
/shop/gen-r9000-sars-cov-2-process-control-pellets-507422
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.